Lifestyle changes like reducing caffeine and managing fluid intake are recommended before using medications for overactive bladder. Anticholinergic medicines help reduce bladder contractions, but they ...

A new study suggests that more women are being prescribed beta-3 agonists over anticholinergics for the treatment of overactive bladder (OAB), suggesting that more clinicians may be choosing this ...

PITTSBURGH, Dec. 18, 2025 /PRNewswire/ -- A new retrospective study published in the International Urogynecology Journal (DOI: 10.1007/s00192-025-06209-8) by researchers at Allegheny Health Network's ...

Black individuals are significantly less likely than non-Hispanic White individuals to fill a prescription for a β3-adrenoceptor agonist for overactive bladder (OAB), according to a study published ...

Healthcare professionals may suggest bladder training and lifestyle approaches as the first-line treatment for older adults with overactive bladder (OAB). If symptoms persist, treatment may involve ...

A patient’s decision to take any prescription medication is a very personal one that requires the patient to weigh several variables, including the potential benefit the medication could provide as ...

Newswise — Nearly half of people with symptoms of overactive bladder had to initiate multiple conversations with their doctor before receiving a diagnosis or treatment, according to a national survey ...

Overactive bladder (OAB) is typically not painful, but it can cause significant discomfort and a sudden, strong urge to urinate. OAB causes sudden, involuntary contractions of the bladder muscle, ...

Women treated with antimuscarinics for overactive bladder syndrome are more likely to be diagnosed with depression after treatment onset than overactive bladder patients not treated with the ...

People with Parkinson’s disease may develop an overactive bladder. They can experience a frequent and desperate need to urinate even though their bladders are not full. According to the American ...

Despite an increased risk of cognitive decline associated with anticholinergic medications, Black patients are 54% less likely than White patients to fill the alternative β3-agonist prescription to ...